scholarly journals The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease

2010 ◽  
Vol 4 (3) ◽  
pp. 165-183 ◽  
Author(s):  
Mark C. Houston
Keyword(s):  
Cardiovascular Disease ◽  
Prevention And Treatment ◽  
Treatment Of Hypertension

scholarly journals Inflammation as a determinant of healing response after coronary stent implantation

2021 ◽  
Author(s):  
Dorota Ochijewicz ◽  
Mariusz Tomaniak ◽  
Grzegorz Opolski ◽  
Janusz Kochman
Keyword(s):  
Cardiovascular Disease ◽  
High Risk ◽  
Inflammatory Response ◽  
Percutaneous Coronary Interventions ◽  
Coronary Stent Implantation ◽  
Percutaneous Coronary ◽  
Prevention And Treatment ◽  
Risk Patients ◽  
Excessive Inflammatory Response

AbstractCardiovascular disease remains the leading cause of death and morbidity worldwide. Inflammation plays an important role in the development of atherosclerosis and is associated with adverse clinical outcomes in patients after percutaneous coronary interventions. Data on stent elements that lead to excessive inflammatory response, proper identification of high–risk patients, prevention and treatment targeting residual inflammatory risk are limited. This review aims to present the role of inflammation in the context of evolving stent technologies and appraise the potential imaging modalities in detection of inflammatory response and anti-inflammatory therapies.

The role of carotenoids in the prevention and treatment of cardiovascular disease – Current state of knowledge

2017 ◽  
Vol 38 ◽  
pp. 45-65 ◽  
Author(s):  
Bartosz Kulczyński ◽  
Anna Gramza-Michałowska ◽  
Joanna Kobus-Cisowska ◽  
Dominik Kmiecik
Keyword(s):  
Cardiovascular Disease ◽  
Current State ◽  
Prevention And Treatment

The Evolving Role of Angiotensin Receptor Blockers in Heart Failure

2002 ◽  
Vol 37 (5) ◽  
pp. 474-482
Author(s):  
Patricia A. Howard
Keyword(s):  
Heart Failure ◽  
Cardiovascular Disease ◽  
Angiotensin Receptor Blockers ◽  
Angiotensin Receptor ◽  
Cardiovascular Pharmacotherapy ◽  
The Us ◽  
Prevention And Treatment ◽  
Recent Developments ◽  
Receptor Blockers

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the US, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on the prevention and treatment of cardiovascular disease—if they keep current with developments in drug therapy.

scholarly journals The Role of RIPK1 and RIPK3 in Cardiovascular Disease

2020 ◽  
Vol 21 (21) ◽  
pp. 8174
Author(s):  
Elise DeRoo ◽  
Ting Zhou ◽  
Bo Liu
Keyword(s):  
Cardiovascular Disease ◽  
Protein Kinase ◽  
Current Evidence ◽  
Venous Disease ◽  
Necrotic Cell Death ◽  
Necrotic Cell ◽  
Interacting Protein ◽  
Prevention And Treatment ◽  
Peripheral Arterial

Cardiovascular diseases, including peripheral arterial and venous disease, myocardial infarction, and stroke, are the number one cause of death worldwide annually. In the last 20 years, the role of necroptosis, a newly identified form of regulated necrotic cell death, in cardiovascular disease has come to light. Specifically, the damaging role of two kinase proteins pivotal in the necroptosis pathway, Receptor Interacting Protein Kinase 1 (RIPK1) and Receptor Interacting Protein Kinase 3 (RIPK3), in cardiovascular disease has become a subject of great interest and importance. In this review, we provide an overview of the current evidence supporting a pathologic role of RIPK1 and RIPK3 in cardiovascular disease. Moreover, we highlight the evidence behind the efficacy of targeted RIPK1 and RIPK3 inhibitors in the prevention and treatment of cardiovascular disease.

Sign in / Sign up

Export Citation Format

Share Document